Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms

Ronald M Goldenberg¹, Jeremy D Gilbert^{2

3}, Robyn L Houlden⁴, Tayyab S Khan^{5

6}, Sapna Makhija⁷, C David Mazer^{8

9

10

11}, Jill Trinacty^{12

13

14}, Subodh Verma^{11

15

16}

Affiliations

¹ LMC Diabetes & Endocrinology, Concord, Canada.
² Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, Toronto, Canada.
³ Department of Medicine, University of Toronto, Toronto, Canada.
⁴ Division of Endocrinology and Metabolism, Queen's University, Kingston, Canada.
⁵ Division of Endocrinology and Metabolism, St. Joseph's Healthcare Centre, London, Canada.
⁶ Department of Medicine, Western University, London, Canada.
⁷ GI Health Centre, Burlington, Canada.
⁸ Department of Anesthesia, St. Michael's Hospital of Unity Health Toronto, Toronto, Canada.
⁹ Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Canada.
¹⁰ Department of Physiology, University of Toronto, Toronto, Canada.
¹¹ Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.
¹² LMC Diabetes & Endocrinology, Ottawa, Canada.
¹³ Department of Medicine, Queensway Carleton Hospital, Ottawa, Canada.
¹⁴ Bruyère Continuing Care, Ottawa, Canada.
¹⁵ Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, Canada.
¹⁶ Department of Surgery, University of Toronto, Toronto, Canada.

PMID: 39871617
DOI: 10.1080/03007995.2025.2458538

Review

Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms

Ronald M Goldenberg et al. Curr Med Res Opin. 2025 Mar.

. 2025 Mar;41(3):403-419.

doi: 10.1080/03007995.2025.2458538. Epub 2025 Jan 31.

Authors

Ronald M Goldenberg¹, Jeremy D Gilbert^{2

3}, Robyn L Houlden⁴, Tayyab S Khan^{5

6}, Sapna Makhija⁷, C David Mazer^{8

9

10

11}, Jill Trinacty^{12

13

14}, Subodh Verma^{11

15

16}

Affiliations

¹ LMC Diabetes & Endocrinology, Concord, Canada.
² Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, Toronto, Canada.
³ Department of Medicine, University of Toronto, Toronto, Canada.
⁴ Division of Endocrinology and Metabolism, Queen's University, Kingston, Canada.
⁵ Division of Endocrinology and Metabolism, St. Joseph's Healthcare Centre, London, Canada.
⁶ Department of Medicine, Western University, London, Canada.
⁷ GI Health Centre, Burlington, Canada.
⁸ Department of Anesthesia, St. Michael's Hospital of Unity Health Toronto, Toronto, Canada.
⁹ Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Canada.
¹⁰ Department of Physiology, University of Toronto, Toronto, Canada.
¹¹ Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.
¹² LMC Diabetes & Endocrinology, Ottawa, Canada.
¹³ Department of Medicine, Queensway Carleton Hospital, Ottawa, Canada.
¹⁴ Bruyère Continuing Care, Ottawa, Canada.
¹⁵ Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, Canada.
¹⁶ Department of Surgery, University of Toronto, Toronto, Canada.

PMID: 39871617
DOI: 10.1080/03007995.2025.2458538

Erratum in

Correction.
[No authors listed] [No authors listed] Curr Med Res Opin. 2025 Mar;41(3):i. doi: 10.1080/03007995.2025.2473240. Epub 2025 Feb 26. Curr Med Res Opin. 2025. PMID: 40012208 No abstract available.

Abstract

The GLP-1 receptor-based agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2i) are major twenty first century breakthroughs in diabetes and obesity medicine but there are important safety considerations regarding the perioperative and periprocedural management of individuals who are treated with these agents. GLP-1RAs have been linked to an increased risk of retained gastric contents and pulmonary aspiration while SGLT2i can be associated with diabetic ketoacidosis. This manuscript provides a narrative review of the available evidence for perioperative and periprocedural risks in people prescribed GLP-1RAs and SGLT2i. The authors provide expert opinion-driven recommendations and algorithms on how to safely manage GLP-1RAs and SGLT2i under perioperative/periprocedural settings.

Keywords: GLP-1RA; SGLT2i; aspiration; ketoacidosis; perioperative; periprocedure.

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- figshare - Access datasets and other research materials.
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms

Affiliations

Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms

Authors

Affiliations

Erratum in

Abstract

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous